DDB BOARD REGULATION NO. 3, s. 1975, April 10, 1975
[ DDB BOARD REGULATION NO. 3, s. 1975, April 10, 1975 ]
EXCLUSION OF THE PRODUCT MERCODOL WITH IPECAC FROM THE LIST OF PROHIBITED DRUGS
Pursuant to the powers vested in the Dangerous Drugs Board under Section 36(a) of R.A. 6425, as amended, the following drug is hereby classified as an exempt preparation, the provisions of Board Regulation No. 5, series of 1974, notwithstanding.
Mercodol with Decapryn Cough Syrup with the following formulation and label indications:
Each teaspoonful (5 cc) contains:
Ipecac (total alkaloids 0.35 mg.
Mercodeinone (dihydrocodeinone
bitartrate N.F.) 1.66 mg.
(Warning: May be habit forming)
Nethamine (etafedrine hydrochloride 16.60 mg.
Decapryn (doxylamine succinate) 6.00 mg.
Sodium Citrate 200.00 mg.
Alcohol 5%
Caution: "Contains Ipecac — Recommended dose must not be exceeded."
As herein classified, the above named preparation may be prescribed under ordinary prescriptions wherein the D-1(2) and S-2 licenses of the prescribing physicians, and the name and address of the patient should be indicated.
This Regulation shall take effect immediately.
Adopted: 10 April 1975
(SGD.) CLEMENTE S. GATMAITAN, M.D., M.P.H.
Chairman
Want an analysis of this document?
Ask ASG Legal AI to summarize it, compare it with other rulings, or explain how it applies to your situation — it researches from this same library.